Your browser doesn't support javascript.
loading
Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial.
Wei, Lai; Zhao, Tingting; Zhang, Ji; Mao, Qing; Gong, Guozhong; Sun, Yongtao; Chen, Yongping; Wang, Maorong; Tan, Deming; Gong, Zuojiong; Li, Baosen; Niu, Junqi; Li, Shuchen; Gong, Huanyu; Zou, Liyun; Zhou, Wei; Jia, Zhengcai; Tang, Yan; Fei, Lei; Hu, Yang; Shang, Xiaoyun; Han, Junfeng; Zhang, Bei; Wu, Yuzhang.
Afiliação
  • Wei L; Peking University People's Hospital, Peking University Hepatology institute, Beijing, China.
  • Zhao T; Chongqing International Institute for Immunology, Chongqing, China.
  • Zhang J; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
  • Mao Q; Infectious Diseases Institute of PLA, Southwest Hospital, Army Medical University, Chongqing, China.
  • Gong G; Infectious Diseases Department, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Sun Y; Infectious Diseases Department, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • Chen Y; Infectious Diseases Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wang M; Infectious Diseases Department, The 81th Hospital of PLA, Nanjing, China.
  • Tan D; Infectious Diseases Department, Xiangya Hospital of Central South University, Changsha, China.
  • Gong Z; Infectious Diseases Department, Renmin Hospital of Wuhan University, Wuhan, China.
  • Li B; Infectious Diseases Department, 302 Military Hospital, Beijing, China.
  • Niu J; Infectious Diseases Department, The First Hospital of Jilin University, Changchun, China.
  • Li S; Infectious Diseases Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Gong H; Infectious Diseases Department, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Zou L; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
  • Zhou W; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
  • Jia Z; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
  • Tang Y; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
  • Fei L; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
  • Hu Y; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
  • Shang X; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
  • Han J; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
  • Zhang B; Department of Immunology, Medical College of Qingdao University, Qingdao, China.
  • Wu Y; Institute of Immunology, PLA, Army Medical University, Chongqing, China.
Hepatology ; 75(1): 182-195, 2022 01.
Article em En | MEDLINE | ID: mdl-34396571
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Hepatite Viral / Vírus da Hepatite B / Hepatite B Crônica / Antígenos E da Hepatite B Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Hepatite Viral / Vírus da Hepatite B / Hepatite B Crônica / Antígenos E da Hepatite B Idioma: En Ano de publicação: 2022 Tipo de documento: Article